Drugmaker drops cheaper version of drug, leaving patients stuck with pricier one
3 years, 1 month ago

Drugmaker drops cheaper version of drug, leaving patients stuck with pricier one

NPR  

Drugmaker drops cheaper version of drug, leaving patients stuck with pricier one Enlarge this image toggle caption Kristina Barker for KHN Kristina Barker for KHN Sudeep Taksali thought his battle to avoid a medication's steep price tag was over. Enlarge this image toggle caption Kristina Barker for KHN Kristina Barker for KHN Then, in September, Endo told the FDA it stopped making Vantas for good. When Endo investigated its Vantas manufacturing problem, it wasn't able to find "a suitable corrective action that resolves the issue," Zoumas Lubeski says. Enlarge this image toggle caption Kristina Barker for KHN Kristina Barker for KHN As a result of limited FDA power, a lot about drug shortages is opaque, Fox says.

Puberty Company Fox Fda Npr Sponsor Message Coleman Product Kristina Endo Khn Drugmaker Drops Vantas Taksali Central Precocious Puberty Khn Kristina Barker Zoumas Lubeski Supprelin Kristina Barker  npr  drugmaker  drops  stuck  puberty  product  vantas  drug  fda  supprelin  cheaper  kristina  version  company  patients  pricier  endo  leaving

Discover Related